Polymorphism in the interleukin-17A promoter contributes to gastric cancer

World Journal of Gastroenterology

Volumn 19, Issue 34, 2013, Pages 5693-5699

  Rafiei, Alireza ^a   Hosseini, Vahid ^b   Janbabai, Ghasem ^c   Ghorbani, Abuzar ^a   Ajami, Abulghasem ^a   Farzmandfar, Touraj ^a   Azizi, Maedeh Darzyani ^a   Gilbreath, Jeremy J ^d   Merrell, D Scott ^d  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Imam Hospital   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Department of Microbiology and Immunology   (Iran)

Author keywords

Cancer; Gastric cancer; Helicobacter pylori; Interleukin 17A

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 17;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HELICOBACTER INFECTION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ADENOCARCINOMA; STOMACH CANCER;

CANCER; GASTRIC CANCER; HELICOBACTER PYLORI; INTERLEUKIN-17A;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-17; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84883888831     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i34.5693     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078]
2. Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer 2009; 125: 1953-1960 [PMID: 19569234 DOI: 10.1002/ijc.24499]
3. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, Yoonessi A, Tavangar M, Abedi BA, Sotoudehmanesh R, Pourshams A, Asgari AA, Doulatshahi S, Alizadeh BZ, Arshi S, Madjidpoor A, Mir Moomen S, Fleischer DE. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcino-ma in the northwest of Iran. J Clin Pathol 2004; 57: 37-42 [PMID: 14693833]
4. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, No-uraie M, Yazdanbod A, Tavangar SM, Mikaeli J, Merat S, Malekzadeh R. Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci 2008; 53: 27-33 [PMID: 17492381 DOI: 10.1007/s10620-007-9817-1]
5. Joossens JV, Hill MJ, Elliott P, Stamler R, Lesaffre E, Dyer A, Nichols R, Kesteloot H. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996; 25: 494-504 [PMID: 8671549]
6. Pakseresht M, Forman D, Malekzadeh R, Yazdanbod A, West RM, Greenwood DC, Crabtree JE, Cade JE. Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control 2011; 22: 725-736 [PMID: 21347819]
7. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005; 96: 1-6 [PMID: 15649247]
8. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83 [PMID: 17577615 DOI: 10.1007/s10120-007-0420-0]
9. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleu-kin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402 [PMID: 10746728 DOI: 10.1038/35006081]
10. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-636 [PMID: 15579481]
11. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517 [PMID: 19132915 DOI: 10.1146/annurev.immunol.021908.132710]
12. Moseley TA, Haudenschild DR, Rose L, Reddi AH. In-terleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174 [PMID: 12651226 DOI: 10.1016/ S1359-6101(03)00002-9]
13. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155: 5483-5486 [PMID: 7499828]
14. Espinoza JL, Takami A, Onizuka M, Kawase T, Sao H, Akiyama H, Miyamura K, Okamoto S, Inoue M, Ohtake S, Fukuda T, Morishima Y, Kodera Y, Nakao S. A single nucleo-tide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT. Bone Marrow Transplant 2011; 46: 1455-1463 [PMID: 21217785 DOI: 10.1038/bmt.2010.325]
15. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The infuence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 2008; 28: 44-49 [PMID: 17828618 DOI: 10.1007/s10875-007-9125-8]
16. Amedei A, Munari F, Bella CD, Niccolai E, Benagiano M, Bencini L, Cianchi F, Farsi M, Emmi G, Zanotti G, de Bernard M, Kundu M, D'Elios MM. Helicobacter pylori secreted pep-tidyl prolyl cis, trans-isomerase drives Th17 infammation in gastric adenocarcinoma. Intern Emerg Med 2012; Epub ahead of print [PMID: 23054412 DOI: 10.1007/s11739-012-0867-9]
17. Shibata T, Tahara T, Hirata I, Arisawa T. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcino-genesis. Hum Immunol 2009; 70: 547-551 [PMID: 19414056 DOI: 10.1016/j.humimm.2009.04.030]
18. Wu X, Zeng Z, Chen B, Yu J, Xue L, Hao Y, Chen M, Sung JJ, Hu P. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 2010; 127: 86-92 [PMID: 19904747 DOI: 10.1002/ ijc.25027]
19. Liu XK, Lin X, Gaffen SL. Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem 2004; 279: 52762-52771 [PMID: 15459204 DOI: 10.1074/jbc.M405764200]
20. Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma L, Xue X, Wei G, Liu X, Fang G. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008; 374: 533-537 [PMID: 18655770 DOI: 10.1016/j.bbrc.2008.07.060]
21. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classifcation. Acta Pathol Microbiol Scand 1965; 64: 31-49 [PMID: 14320675]
22. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. 18 ed. New York: McGraw-Hill, 2011
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215 [PMID: 3344216]
24. Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, Hayakawa N, Kajiyama G. Enhanced expression of induc-ible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res 1999; 5: 1411-1415 [PMID: 10389926]
25. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Heli-cobacter pylori. Association of specifc vacA types with cyto-toxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777 [PMID: 7629077]
26. Oleastro M, Cordeiro R, Ménard A, Yamaoka Y, Queiroz D, Mégraud F, Monteiro L. Allelic diversity and phylog-eny of homB, a novel co-virulence marker of Helicobacter pylori. BMC Microbiol 2009; 9: 248 [PMID: 19954539 DOI: 10.1186/1471-2180-9-248]
27. Oleastro M, Cordeiro R, Yamaoka Y, Queiroz D, Mégraud F, Monteiro L, Ménard A. Disease association with two Helico-bacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog 2009; 1: 12 [PMID: 19545429 DOI: 10.1186/1757-4749-1-12]
28. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mo-hagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastro-enterology 2007; 133: 926-936 [PMID: 17854597 DOI: 10.1053/ j.gastro.2007.06.056]
29. Costa VS, Mattana TC, da Silva ME. Unregulated IL-23/ IL-17 immune response in autoimmune diseases. Diabetes Res Clin Pract 2010; 88: 222-226 [PMID: 20392505 DOI: 10.1016/ j.diabres.2010.03.014]
30. Zhang X, Pei F, Zhang M, Yan C, Huang M, Wang T, Han Y. Interleukin-17A gene variants and risk of coronary artery disease: a large angiography-based study. Clin Chim Acta 2011; 412: 327-331 [PMID: 21062626 DOI: 10.1016/j.cca.2010.10.027]
31. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70 [PMID: 12477762]
32. Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Førre ØT, Helgetveit K, Kvien TK, Lie BA. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) 2009; 48: 367-370 [PMID: 19208686 DOI: 10.1093/ rheumatology/ken512]
33. Fox JG, Wang TC. Infammation, atrophy, and gastric cancer. J Clin Invest 2007; 117: 60-69 [PMID: 17200707 DOI: 10.1172/ JCI30111]